Antibacterial Envelope Use for the Prevention of Surgical Site Infection in Spinal Cord Stimulator Implantation Surgery: A Retrospective Review of 52 Cases
Open Access
- 1 July 2021
- journal article
- review article
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 14, 2249-2254
Abstract
Objective: Surgical site infection in patients who undergo spinal cord stimulator implant surgery represents a significant concern in terms of increased health care costs and patient morbidity. The use of antibacterial envelopes in spinal cord stimulator implant surgeries has not been previously described. The aim of this retrospective review was to evaluate the effectiveness of the antibacterial envelope in reducing surgical site infection in spinal cord stimulator implant surgeries when used adjunctively to standard infection prevention measures. Materials and Methods: The study included 52 patients, all of whom were implanted with a spinal cord stimulator between January 2015 and November 2020. To be included, patients were required to have had an antibacterial envelope utilized at the time of surgery. Patient records were retrospectively reviewed. All patients who received an antibacterial envelope at the time of implant surgery were included. Results: Data was collected and analyzed on 52 permanent SCS implantations, including primary implantation (n=26) and revision surgery (n=26). All patients were at least three months post-operative from the implant surgery (average follow-up time period was 518.4 days). There were no surgical site infections reported in the 52 patient cohort. Conclusion: Antibiotic impregnated envelopes appear to be a safe and effective modality to decrease surgical site infection risk in spinal cord stimulation implant surgeries.Keywords
This publication has 12 references indexed in Scilit:
- Spinal Cord Stimulation Infection Rate and Incremental Annual Expenditures: Results From a United States Payer DatabaseNeuromodulation: Technology at the Neural Interface, 2019
- Spinal Cord Stimulation Infection Rate and Risk Factors: Results From a United States Payer DatabaseNeuromodulation: Technology at the Neural Interface, 2018
- Spinal Cord Stimulator Related Infections: Findings From a Multicenter Retrospective Analysis of 2737 ImplantsNeuromodulation: Technology at the Neural Interface, 2017
- Spinal Cord Stimulator Implant Infection Rates and Risk Factors: A Multicenter Retrospective StudyNeuromodulation: Technology at the Neural Interface, 2017
- Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017JAMA Surgery, 2017
- The Neurostimulation Appropriateness Consensus Committee (NACC) Recommendations for Infection Prevention and ManagementNeuromodulation: Technology at the Neural Interface, 2017
- An International Survey to Understand Infection Control Practices for Spinal Cord StimulationNeuromodulation: Technology at the Neural Interface, 2016
- The Surgical Infection Prevention and Surgical Care Improvement Projects: Promises and PitfallsThe American Surgeon™, 2006
- Healthcare Epidemiology: The Surgical Infection Prevention and Surgical Care Improvement Projects: National Initiatives to Improve Outcomes for Patients Having SurgeryClinical Infectious Diseases, 2006
- Spinal Cord Stimulation for Chronic Back and Leg Pain and Failed Back Surgery Syndrome: A Systematic Review and Analysis of Prognostic FactorsSpine, 2005